Hims & Hers Health financials
$28.70−0.28%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753.2M | $608.1M | $617.8M | $599.0M | $544.8M | $586.0M | $481.1M | $401.6M | $315.6M | $278.2M | $246.6M | $226.7M |
| Gross profit | $480.8M | $396.8M | $444.4M | $442.1M | $416.2M | $430.7M | $369.5M | $317.9M | $256.6M | $229.1M | $204.1M | $187.3M |
| Gross margin | 63.8% | 65.2% | 71.9% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% | 81.3% | 82.4% | 82.7% | 82.6% |
| Operating income | -$97.2M | -$78.3M | $9.2M | $11.8M | $26.7M | $57.9M | $18.6M | $22.4M | $11.0M | $9.9M | -$400.0K | -$8.6M |
| Net income | -$86.3M | -$92.1M | $20.6M | $15.8M | $42.5M | $49.5M | $26.0M | $75.6M | $13.3M | $11.1M | $1.2M | -$7.6M |
| Net margin | −11.5% | −15.1% | 3.3% | 2.6% | 7.8% | 8.4% | 5.4% | 18.8% | 4.2% | 4.0% | 0.5% | −3.3% |
| Diluted EPS | $-0.37 | $-0.40 | $0.07 | $0.06 | $0.17 | $0.20 | $0.10 | $0.32 | $0.06 | $0.05 | $0.01 | $-0.04 |
| EBITDA | -$67.7M | -$56.4M | $27.3M | $29.5M | $37.2M | $66.2M | $24.7M | $26.8M | $14.7M | $12.9M | -$400.0K | -$6.2M |
| Operating cash flow | -$35.9M | $89.4M | $61.3M | $148.7M | -$19.1M | $109.1M | $86.4M | $85.3M | $53.6M | $25.8M | $22.0M | $25.2M |
| Free cash flow | -$61.9M | $59.5M | -$2.6M | $79.4M | -$65.2M | $53.8M | $59.5M | $79.4M | $47.6M | $11.9M | $10.8M | $19.3M |
| Diluted shares | 231.7M | 228.4M | 280.9M | 248.7M | 256.8M | 246.6M | 248.0M | 235.1M | 234.8M | 229.4M | 211.7M | 210.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $609.8M | $222.3M | $228.6M | $345.8M | $1.12B | $273.7M |
| Short-term investments | $231.2M | $528.6M | $348.9M | $284.0M | $20.0M | $48.9M |
| Total debt | $1.37B | $974.1M | $972.6M | $971.0M | $969.5M | $0.00 |
| Total assets | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | $891.7M |
| Total liabilities | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | $342.4M |
| Shareholders' equity | $324.1M | $446.2M | $540.9M | $581.0M | $562.7M | $549.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology